QVA Mechanistic Efficacy Study (Receptor Effects, Etc)
Clinical trial NCT02634983 · COMPLETED
Trial details
- NCT number
- NCT02634983
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-03
- Primary completion
- 2017-09-26
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.